As the peak of the 2020-2021 flu season approaches in the US, InCrowd wanted to understand the perceptions and expectations of HCPs on patient and facility response to both the flu vaccine and the COVID-19 vaccine, and how both of these coinciding viruses will influence one another through the rest of 2020 and 2021.

* Please note, views in this survey reflect opinions only as reported by responding physicians.

Methodology:

• Method:
  • 6-Minute MicroSurvey via InCrowd
• Crowds:
  • Healthcare Practitioners (HCPs) that administer the flu vaccine
• Sample Size:
  • n = 334
    • Office-based, hospital, and retail
• Fielding Period:
  • December 2nd – 8th

InCrowd’s other COVID-19 Tracking Reports:

• • InCrowd Novel Coronavirus (COVID-19) Vaccine Development – Wave 2
  • Telemedicine & Remote-Patient Monitoring Report
  • Physician Tracking Report – Wave 6
  • Non-Frontline Specialist Tracking Report – Wave 2
  • Patient Tracking Report – Wave 3
  • Treatment & Outcomes of Diabetes Patients During the COVID-19 Pandemic